Reassessing the Cardiovascular Safety of Febuxostat: Implications of the Febuxostat versus Allopurinol Streamlined Trial

被引：14
|
作者：
Choi, Hyon K. [1 ]
Neogi, Tuhina [2 ]
Stamp, Lisa K. [3 ]
Terkeltaub, Robert [4 ,5 ]
Dalbeth, Nicola [6 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Boston Univ, Sch Med, Boston, MA 02118 USA
[3] Univ Otago, Christchurch, New Zealand
[4] VA San Diego Healthcare Syst, San Diego, CA USA
[5] Univ Calif San Diego, La Jolla, CA 92093 USA
[6] Univ Auckland, Auckland, New Zealand
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷 / 05期
关键词：
D O I：
10.1002/art.41638
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：721 / 724
页数：4
相关论文
共 50 条
  • [21] Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert
    Choi, Hyon
    Neogi, Tuhina
    Stamp, Lisa
    Dalbeth, Nicola
    Terkeltaub, Robert
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (11) : 1702 - 1709
  • [22] Febuxostat versus allopurinol for patients with gout: is it time to overcome concerns regarding cardiovascular safety?
    Patoulias, Dimitrios Ioannis
    Doumas, Michael
    REUMATOLOGIA, 2021, 59 (06): : 423 - 424
  • [23] Febuxostat vs allopurinol: real-world cardiovascular safety
    Reactions Weekly, 2019, 1762 (1) : 6 - 6
  • [24] Cardiovascular Safety of Febuxostat
    Vanessa Perez-Gomez, M.
    Bartsch, Lorenz-Alexander
    Ortiz, Alberto
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (16): : 1583 - 1583
  • [25] Demographics of the Patient Population Recruited into the Febuxostat vs. Allopurinol Streamlined Trial (FAST)
    Jennings, Claudine
    Mackenzie, Isla S.
    Flynn, Rob
    Ford, Ian
    Nuki, George
    MacDonald, Thomas M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 400 - 400
  • [26] Cardiovascular safety of febuxostat and allopurinol in patients with gout: A meta-analysis
    Guan, Xudong
    Zhang, Shengzhao
    Liu, Jiayan
    Wu, Fengbo
    Zhou, Lingyan
    Liu, Ying
    Su, Na
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [27] Cardiovascular Safety of Febuxostat Versus Allopurinol in the Real World: Old Reliable Comes Out on Top
    Mankad, Rekha
    MAYO CLINIC PROCEEDINGS, 2019, 94 (07) : 1128 - 1130
  • [28] General Safety of Febuxostat and Allopurinol in a Cardiovascular Outcomes Study in Patients with Gout
    Saag, Kenneth
    Becker, Michael A.
    White, William B.
    Whelton, Andrew
    Borer, Jeffrey
    Gorelick, Philip
    Hunt, Barbara
    Castillo, Majin
    Gunawardhana, Lhanoo
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [29] FEBUXOSTAT, ALLOPURINOL AND CARDIOVASCULAR RISK: MYTH OR REALITY?
    MacDonald, Thomas
    RHEUMATOLOGY, 2019, 58
  • [30] Diabetes and gout: efficacy and safety of febuxostat and allopurinol
    Becker, M. A.
    MacDonald, P. A.
    Hunt, B. J.
    Jackson, R. L.
    DIABETES OBESITY & METABOLISM, 2013, 15 (11): : 1049 - 1055
12345